Finland· FI-REL-REL50447
Maviret
A glecaprevir and pibrentasvir product containing glecaprevir + pibrentasvir, registered in Finland by AbbVie Deutschland GmbH&Co.KG. The same ATC class is registered in 15 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Glecaprevir and pibrentasvir is registered in 15 of 19 countries.
Countries holding a registration under ATC J05AP57 (glecaprevir and pibrentasvir), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 10 of them publish a price we can compare per daily dose
Glecaprevir and pibrentasvir · ATC J05AP57
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Glecaprevir + Pibrentasvir
- Manufacturer
- AbbVie Deutschland GmbH&Co.KG
- Country
- Finland (FI)
- ATC code
- J05AP57
- ATC class
- Glecaprevir and pibrentasvir
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Glecaprevir and pibrentasvir in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomGlecaprevir 100mg / Pibrentasvir 40mg tabletsAbbVie Ltd
- United StatesMavyretAbbVie Inc.
- SpainMAVIRET 100 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAbbvie Deutschland Gmbh & Co. Kg
- FranceMAVIRET 100 mg/40 mg, comprimé pelliculéABBVIE DEUTSCHLAND (ALLEMAGNE)
- IrelandMaviret 100 mg/40 mg film-coated tabletsAbbVie Deutschland GmbH & Co. KG
- CzechiaMAVIRETAbbVie Deutschland GmbH & Co.KG, Ludwigshafen
- PolandMaviretAbbVie Deutschland GmbH & Co. KG
- SwedenMaviret 100 mg/40 mg Filmdragerad tablettAbbVie Deutschland GmbH & Co KG
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Glecaprevir/Pibrentasvir Abbvie
- Iceland · Maviret
- Liechtenstein · Maviret
- Norway · Maviret
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2074991e-eb3b-4e4f-83f2-8b515d2731a2 GET /v1/drugs/2074991e-eb3b-4e4f-83f2-8b515d2731a2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "3",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "ED",
"strength": "100 mg / 40 mg",
"atc_label": "glekapreviiri ja pibrentasviiri",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/17/1213/001",
"fimea_rel_id": "REL50447",
"authorised_at": "2017-07-26"
}See everything about glecaprevir and pibrentasvir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.